Alexandria Real Estate Equities, Inc. Refreshes and Extends Its $500 Million Common Stock Repurchase Program

Core Viewpoint - Alexandria Real Estate Equities, Inc. has announced a new common stock repurchase program, replacing the previous authorization of up to $500 million, which was set to expire on December 31, 2025 [1] Group 1: Stock Repurchase Program - The new program allows the company to repurchase up to $500 million of its outstanding shares of common stock until December 31, 2026 [1] - Under the previous program, Alexandria repurchased $258.2 million of its shares primarily in January 2025 [1] - The specific timing, price, and amount of repurchases will be at the company's discretion and influenced by various factors such as stock prices and market conditions [2] Group 2: Funding and Conditions - The company prefers to fund stock repurchases on a leverage-neutral basis using net cash from operating activities after dividends and proceeds from real estate dispositions or joint ventures [2] - The stock repurchase program does not obligate the company to repurchase any specific dollar amount or number of shares and may be suspended or discontinued at any time [2] Group 3: Company Overview - Alexandria is a leading life science REIT, founded in 1994, and is recognized for its role in pioneering the life science real estate niche [3] - The company operates in key life science innovation cluster locations, including Greater Boston, San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City [3]